NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Tend to agree the journal article will not have a significant influence on the share price; maybe it gets us back above $1 plus. The article is more of a catalyst to get to the more important matters of an up list and to satisfying a condition for a partnership.

The key will be how quickly they transition from the journal article to announcement of the ASM and proxy, along with the other events above. They’ve certainly had enough time to prepare, so the ASM and proxy should be announced and available within a few days afterwords.

ATL, I don't doubt the importance of the journal article, or the importance it would have in validating and verifying the DCVax-L trial results. I just doubt the article will have the significant impact on the NWBO share price that if would have if accepted and published in a shorter time frame once the initial phase 3 results were announced.